Feng Jin Hui Zhu Li Kong Jinming Yu
10.2147/OTT.S83888
Onco Targets Ther
2015 Apr 23;8:943-6.
clinical marker cutaneous toxicity epidermal growth factor receptor inhibition erlotinib non-small-cell lung cancer
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/25960666/
Case Reports
PMC4410898
25960666
A spectrum of cutaneous toxicities from erlotinib may be a robust clinical marker for non-small-cell lung therapy: a case report and literature review
2015